Wikidata

(Q53243881)

English

Cost-utility of adjuvant hormone therapies with aromatase inhibitors in post-menopausal women with breast cancer: upfront anastrozole, sequential tamoxifen-exemestane and extended tamoxifen-letrozole.

scientific article published on 4 January 2007

In more languages
default values for all languages
No label defined

No description defined

Statements

title
Cost-utility of adjuvant hormone therapies with aromatase inhibitors in post-menopausal women with breast cancer: upfront anastrozole, sequential tamoxifen-exemestane and extended tamoxifen-letrozole. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17207623
retrieved
12 May 2018
reference URL
http://europepmc.org/abstract/MED/17207623

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q53243881&oldid=1650620443"